https://news.medxy.ai/ja/67752-2/Medxy AIja2026-08-27T14:31:00-07:00糖尿病におけるApo A-Iの特定部位の糖化は、HDL機能を障害し、動脈硬化を促進する https://news.medxy.ai/vi/glycation-apoai-hdl/Medxy AIvi2026-08-27T14:30:00-07:00Glycat hóa apo AI theo từng vị trí làm suy giảm chức năng HDL và thúc đẩy xơ vữa động mạch trong đái tháo đường https://news.medxy.ai/zh/67742-2/Medxy AIzh2026-08-27T14:29:00-07:00心肌梗死幸存者坚持不同饮食模式与死亡率的关联 https://news.medxy.ai/vi/eating-patterns-mortality/Medxy AIvi2026-08-27T14:29:00-07:00Tuân thủ các mô hình ăn uống khác nhau có liên quan như thế nào đến tử vong ở người sống sót sau nhồi máu cơ tim? Tổng quan dựa trên bằng chứng https://news.medxy.ai/zh/energy-restriction-gestational-diabetes/Medxy AIzh2026-08-27T14:01:12-07:00妊娠晚期能量限制对妊娠期糖尿病母婴体成分的影响：DiGest随访研究见解 https://news.medxy.ai/ja/energy-restriction-gestational-diabetes/Medxy AIja2026-08-27T14:00:53-07:00妊娠糖尿病における第3三半期のエネルギー制限が母児の体組成に及ぼす影響：DiGest追跡研究からの知見 https://news.medxy.ai/vi/68351-2/Medxy AIvi2026-08-27T14:00:32-07:00 https://news.medxy.ai/zh/cpvl-pigr-cardiotoxicity/Medxy AIzh2026-08-27T13:59:30-07:00血浆生物标志物CPVL与PIGR可预测血液肿瘤患者蒽环类心脏毒性 https://news.medxy.ai/ja/anthracycline-cardiotoxicity-biomarkers/Medxy AIja2026-08-27T13:59:12-07:00アントラサイクリン誘発心毒性を予測する血漿バイオマーカー：CPVL と PIGR の可能性 https://news.medxy.ai/vi/cpvl-pigr-toxicity-prediction/Medxy AIvi2026-08-27T13:58:53-07:00CPVL và PIGR trong huyết tương dự đoán độc tính trên tim do anthracycline ở bệnh nhân ung thư huyết học https://news.medxy.ai/zh/heart-failure-gender-differences/Medxy AIzh2026-08-27T13:57:51-07:00射血分数降低的心力衰竭中：骨骼肌炎症与功能障碍的性别差异 https://news.medxy.ai/ja/sex-differences-muscle-inflammation/Medxy AIja2026-08-27T13:57:34-07:00駆出率低下心不全における性差別骨格筋炎症と筋機能障害 https://news.medxy.ai/vi/muscle-inflammation-heart-failure/Medxy AIvi2026-08-27T13:57:15-07:00Viêm cơ vân và rối loạn chức năng cơ khác nhau theo giới tính trong suy tim phân suất tống máu giảm https://news.medxy.ai/zh/68338-2/Medxy AIzh2026-08-27T13:56:19-07:00 https://news.medxy.ai/ja/immune-mediated-disease/Medxy AIja2026-08-27T13:56:00-07:00免疫介在性疾患と中心性漿液性脈絡網膜症：MICRoN Report 21からみた臨床的知見 https://news.medxy.ai/ja/aortic-valve-replacement/Medxy AIja2026-08-27T13:55:58-07:00慢性大動脈弁逆流における弁置換後の心筋線維化と逆リモデリング：最新知見と臨床的意義 https://news.medxy.ai/vi/68335-2/Medxy AIvi2026-08-27T13:55:32-07:00 https://news.medxy.ai/zh/right-ventricle-function/Medxy AIzh2026-08-27T13:54:16-07:00右心室功能、临床结局与vutrisiran在合并心肌病的转甲状腺素蛋白淀粉样变性中的作用：HELIOS-B试验的新认识 https://news.medxy.ai/ja/right-ventricle-function/Medxy AIja2026-08-27T13:53:50-07:00トランスサイレチンアミロイドーシス心筋症における右室機能、臨床転帰、vutrisiranの効果：HELIOS-B試験からの知見 https://news.medxy.ai/vi/right-ventricle-function/Medxy AIvi2026-08-27T13:53:24-07:00Chức năng thất phải, kết cục lâm sàng và tác động của vutrisiran trong amyloidosis transthyretin có bệnh cơ tim: dữ liệu từ thử nghiệm HELIOS-B https://news.medxy.ai/zh/67968-2/Medxy AIzh2026-08-27T12:54:00-07:00精神分裂症的复发轨迹与抗精神病药物停药：基于荟萃分析与当代证据的见解 https://news.medxy.ai/adult-overweight-and-obesity-management-key-updates-from-the-2025-va-dod-clinical-practice-guideline/Medxy AIen2026-08-27T12:49:00-07:00Adult Overweight and Obesity Management: Key Updates from the 2025 VA/DoD Clinical Practice Guideline https://news.medxy.ai/early-red-blood-cell-transfusion-strategy-in-septic-shock-among-cancer-patients-insights-from-the-transport-randomized-controlled-trial/Medxy AIen2026-08-27T12:35:00-07:00Early Red Blood Cell Transfusion Strategy in Septic Shock Among Cancer Patients: Insights from the TRANSPORT Randomized Controlled Trial https://news.medxy.ai/ja/schizophrenia-relapse-antipsychotics/Medxy AIja2026-08-27T11:54:00-07:00統合失調症における再発経過と抗精神病薬中止：メタ解析と最新エビデンスからみた知見 https://news.medxy.ai/zh/breaking-communication-barriers/Medxy AIzh2026-08-27T11:09:00-07:00打通共享气道管理中的沟通壁垒：来自多中心麻醉科医师调查的启示 https://news.medxy.ai/discovery-of-a-novel-b-all-subtype-defined-by-ighfendrr-rearrangement-and-kras-mutations-with-poor-chemotherapy-response/Medxy AIen2026-08-27T10:12:00-07:00Discovery of a Novel B-ALL Subtype Defined by IGH::FENDRR Rearrangement and KRAS Mutations With Poor Chemotherapy Response https://news.medxy.ai/vi/antipsychotic-treatment/Medxy AIvi2026-08-27T09:54:00-07:00Quỹ đạo tái phát và ngừng thuốc chống loạn thần trong tâm thần phân liệt: Góc nhìn từ phân tích gộp và bằng chứng hiện đại https://news.medxy.ai/fecal-microbiota-transplantation-a-promising-therapy-for-steroid-refractory-acute-graft-versus-host-disease/Medxy AIen2026-08-27T09:33:00-07:00Fecal Microbiota Transplantation: A Promising Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease https://news.medxy.ai/ja/67832-2/Medxy AIja2026-08-27T09:25:00-07:00脳損傷後の意識障害におけるグルコースおよびメチオニン代謝：探索的縦断PET研究 https://news.medxy.ai/evaluating-the-impact-of-the-mission-act-on-va-specialty-care-referrals-and-wait-times-a-national-cohort-study/Medxy AIen2026-08-27T08:42:00-07:00Evaluating the Impact of the MISSION Act on VA Specialty Care Referrals and Wait Times: A National Cohort Study https://news.medxy.ai/zh/metabolic-signals-consciousness/Medxy AIzh2026-08-27T08:25:00-07:00脑损伤后意识障碍的代谢信号：葡萄糖与蛋氨酸PET成像的新发现 https://news.medxy.ai/zh/non-genetic-effects-ataxia/Medxy AIzh2026-08-27T07:24:00-07:00揭示遗传性共济失调中的非遗传影响：来自SCA6与SCA27B队列的启示 https://news.medxy.ai/ja/parathyroid-preservation/Medxy AIja2026-08-27T07:02:00-07:00全摘甲状腺切除における副甲状腺温存の向上：近赤外自家蛍光プローブ（PTeye）と視診の有効性 https://news.medxy.ai/ja/daratumumab-multiple-myeloma/Medxy AIja2026-08-27T07:00:00-07:00移植非適格の新規診断多発性骨髄腫におけるダラツムマブ＋レナリドミド／デキサメタゾンの長期生存 लाभ――MAIA最終解析が示す意義 https://news.medxy.ai/ja/tp53-mutation-hematopoiesis/Medxy AIja2026-08-27T06:59:00-07:00TP53変異クローン性造血が炎症性表現型を駆動し、CAR-T細胞療法後の不良転帰を予測する https://news.medxy.ai/ja/40-gene-expression-profiles/Medxy AIja2026-08-27T06:57:00-07:0040遺伝子発現プロファイル統合で予後予測がさらに精緻化　高リスク皮膚扁平上皮癌の術後放射線治療判断も支援 https://news.medxy.ai/relapse-trajectories-and-antipsychotic-discontinuation-in-schizophrenia-insights-from-a-meta-analysis-and-contemporary-evidence/Medxy AIen2026-08-27T06:53:00-07:00Relapse Trajectories and Antipsychotic Discontinuation in Schizophrenia: Insights from a Meta-Analysis and Contemporary Evidence https://news.medxy.ai/ja/cd19-car-t-cell-therapy/Medxy AIja2026-08-27T06:44:00-07:00慢性リンパ性白血病におけるCD19 CAR T細胞療法を妨げる免疫老化の重要性 https://news.medxy.ai/ja/tech-supported-meal-counseling/Medxy AIja2026-08-27T06:41:00-07:00テクノロジー支援型食事カウンセリング研修が、プライマリケア研修医の共同意思決定スキルを高める https://news.medxy.ai/ja/67888-2/Medxy AIja2026-08-27T06:39:00-07:00乾癬におけるエピジェネティックな老化の逆転：ティルドラキズマブによる52週間の影響 https://news.medxy.ai/ja/67837-2/Medxy AIja2026-08-27T06:27:00-07:00GLP1R R131Qバリアント：2型糖尿病におけるβ細胞機能の維持とGLP-1受容体作動薬（GLP-1RA）の有効性増強に向けた遺伝的鍵 https://news.medxy.ai/ja/endometrial-hyperplasia-sentinel-biopsy/Medxy AIja2026-08-27T06:22:00-07:00異型子宮内膜過形成におけるセンチネルリンパ節生検の臨床的意義：多施設コホート研究からの知見 https://news.medxy.ai/ja/atopic-dermatitis-care/Medxy AIja2026-08-27T06:19:00-07:00アトピー性皮膚炎管理におけるオンライン診療と対面診療の同等性：大規模ランダム化試験からの示唆 https://news.medxy.ai/ja/quantitative-perfusion-threshold/Medxy AIja2026-08-27T06:17:00-07:00SPY-PHI QPで可視化する定量的灌流閾値：乳房再建における乳房切除皮膚壊死予測と臨床的意義 https://news.medxy.ai/ja/67782-2/Medxy AIja2026-08-27T06:16:00-07:00眼瞼形成術における切開創の閉鎖：皮下縫合と連続縫合のどちらが優れているか？ https://news.medxy.ai/ja/67776-2/Medxy AIja2026-08-27T06:14:00-07:00駆出率低下を伴う心不全の管理最適化：4剤併用療法の遵守および継続に関するスウェーデンのレジストリからの知見 https://news.medxy.ai/optimizing-heart-failure-with-reduced-ejection-fraction-management-insights-from-swedish-registry-on-quadruple-therapy-adherence-and-persistence/Medxy AIen2026-08-27T06:13:00-07:00Optimizing Heart Failure with Reduced Ejection Fraction Management: Insights from Swedish Registry on Quadruple Therapy Adherence and Persistence https://news.medxy.ai/ja/new-b-all-subtype/Medxy AIja2026-08-27T06:12:00-07:00IGH::FENDRR再構成とKRAS変異を有する新規B-ALLサブタイプを発見―化学療法反応不良の背景にある分子機序 https://news.medxy.ai/zh/pteye-parathyroid-protection/Medxy AIzh2026-08-27T06:02:00-07:00PTeye 能否更好保护甲状旁腺？全甲状腺切除术中近红外自发荧光与肉眼识别的比较 https://news.medxy.ai/immunosenescence-as-a-key-barrier-to-cd19-car-t-cell-therapy-in-chronic-lymphocytic-leukemia/Medxy AIen2026-08-27T05:44:00-07:00Immunosenescence as a Key Barrier to CD19 CAR T-Cell Therapy in Chronic Lymphocytic Leukemia https://news.medxy.ai/vi/parathyroid-preservation-2/Medxy AIvi2026-08-27T05:01:00-07:00Tăng cường bảo tồn tuyến cận giáp trong cắt toàn bộ tuyến giáp: Hiệu quả của đầu dò autofluorescence cận hồng ngoại PTeye so với nhận diện bằng mắt thường https://news.medxy.ai/zh/daratumumab-survival-benefit/Medxy AIzh2026-08-27T05:00:00-07:00Daratumumab 联合 Lenalidomide 和 Dexamethasone 的长期生存获益：MAIA 最终分析揭示不适合移植初诊多发性骨髓瘤的新突破 https://news.medxy.ai/vi/daratumumab-benefits/Medxy AIvi2026-08-27T05:00:00-07:00Daratumumab phối hợp lenalidomide và dexamethasone mang lại lợi ích sống còn dài hạn trong đa u tủy xương mới chẩn đoán không đủ điều kiện ghép: Góc nhìn từ phân tích cuối cùng MAIA https://news.medxy.ai/zh/tp53-mutation-inflammation/Medxy AIzh2026-08-27T04:59:00-07:00TP53 突变克隆性造血驱动促炎表型，并提示 CAR T 细胞治疗后预后不良 https://news.medxy.ai/vi/tp53-mutation-car-tcell/Medxy AIvi2026-08-27T04:58:00-07:00Tạo máu dòng vô tính mang đột biến TP53 gây kiểu hình tiền viêm và dự báo kết cục xấu sau liệu pháp CAR T-cell https://news.medxy.ai/vi/40-gene-signature/Medxy AIvi2026-08-27T04:57:00-07:00Hồ sơ biểu hiện 40 gen tích hợp nâng cao độ chính xác tiên lượng và định hướng xạ trị bổ trợ trong ung thư biểu mô tế bào vảy da nguy cơ cao https://news.medxy.ai/zh/adult-obesity-management/Medxy AIzh2026-08-27T04:50:00-07:00成人超重与肥胖管理：2025年VA/DoD临床实践指南关键更新 https://news.medxy.ai/vi/67922-2/Medxy AIvi2026-08-27T04:46:00-07:00Rosiglitazone dùng tại chỗ: Một liệu pháp mới đầy tiềm năng chống xơ hóa cho chứng phù bạch huyết thứ phát https://news.medxy.ai/zh/immune-aging-barrier/Medxy AIzh2026-08-27T04:45:00-07:00免疫衰老：制约慢性淋巴细胞白血病CD19 CAR T细胞治疗的关键障碍 https://news.medxy.ai/vi/diet-consultation-training/Medxy AIvi2026-08-27T04:41:00-07:00Đào tạo tư vấn chế độ ăn có hướng dẫn bằng công nghệ nâng cao kỹ năng ra quyết định chung của bác sĩ nội trú trong chăm sóc ban đầu https://news.medxy.ai/vi/psoriasis-epigenetic-aging/Medxy AIvi2026-08-27T04:39:00-07:00Vảy nến và lão hóa biểu sinh: Tildrakizumab có thể “trẻ hóa” dấu ấn sinh học sau 52 tuần https://news.medxy.ai/zh/fecal-transplant-ghd-treatment/Medxy AIzh2026-08-27T04:34:00-07:00粪菌移植治疗激素难治性急性移植物抗宿主病：一种值得期待的新策略 https://news.medxy.ai/zh/selective-laser-trabeculoplasty/Medxy AIzh2026-08-27T04:31:00-07:00选择性激光小梁成形术在青光眼管理中的长期疗效与视野结局 https://news.medxy.ai/vi/67841-2/Medxy AIvi2026-08-27T04:28:00-07:00Tình trạng suy yếu sau khi xuất viện khỏi ICU ở người cao tuổi sống sót sau sốc nhiễm khuẩn: Các yếu tố dự báo chính và ý nghĩa lâm sàng https://news.medxy.ai/intraday-upper-blepharoplasty-closure-comparing-intradermal-and-continuous-sutures-for-optimal-outcomes/Medxy AIen2026-08-27T03:15:00-07:00Intraday Upper Blepharoplasty Closure: Comparing Intradermal and Continuous Sutures for Optimal Outcomes https://news.medxy.ai/mdadi-composite-score-thresholds-for-efficient-screening-of-swallowing-impairment-in-head-and-neck-cancer-patients/Medxy AIen2026-08-27T00:04:34-07:00MDADI Composite Score Thresholds for Efficient Screening of Swallowing Impairment in Head and Neck Cancer Patients https://news.medxy.ai/clinical-impact-of-sentinel-lymph-node-biopsy-in-atypical-endometrial-hyperplasia-insights-from-a-multicenter-cohort-study/Medxy AIen2026-08-26T23:21:36-07:00Clinical Impact of Sentinel Lymph Node Biopsy in Atypical Endometrial Hyperplasia: Insights from a Multicenter Cohort Study https://news.medxy.ai/comparative-efficacy-and-safety-of-bofanglutide-versus-semaglutide-in-chinese-patients-with-type-2-diabetes-insights-from-a-phase-2b-trial/Medxy AIen2026-08-26T23:20:09-07:00Comparative Efficacy and Safety of Bofanglutide versus Semaglutide in Chinese Patients with Type 2 Diabetes: Insights from a Phase 2b Trial https://news.medxy.ai/equivalence-of-online-and-in-person-care-in-managing-atopic-dermatitis-insights-from-a-large-randomized-trial/Medxy AIen2026-08-26T23:18:46-07:00Equivalence of Online and In-Person Care in Managing Atopic Dermatitis: Insights from a Large Randomized Trial https://news.medxy.ai/defining-a-quantitative-perfusion-threshold-with-spy-phi-qp-to-predict-mastectomy-skin-necrosis-in-breast-reconstruction-insights-and-clinical-implications/Medxy AIen2026-08-26T23:16:57-07:00Defining a Quantitative Perfusion Threshold with SPY-PHI QP to Predict Mastectomy Skin Necrosis in Breast Reconstruction: Insights and Clinical Implications https://news.medxy.ai/zh/67956-2/Medxy AIzh2026-08-26T16:52:00-07:00新型口服食欲素2受体激动剂Alixorexton在1型发作性睡病中显示出良好的安全性和疗效：来自Vibrance-1 II期试验的启示 https://news.medxy.ai/vi/overweight-obesity-management/Medxy AIvi2026-08-26T16:50:00-07:00Quản lý thừa cân và béo phì ở người lớn: Những cập nhật quan trọng từ Hướng dẫn Thực hành Lâm sàng VA/DoD 2025 https://news.medxy.ai/ja/oncoplastic-reconstruction-vs-breast-reduction/Medxy AIja2026-08-26T16:48:00-07:00マクロマスティアにおけるオンコプラスティック再建と乳房縮小術の比較：安全性・満足度・整容性を検証 https://news.medxy.ai/vi/breast-reconstruction-comparison/Medxy AIvi2026-08-26T16:47:00-07:00Tái tạo vú oncoplastic hay thu nhỏ vú hai bên trong phì đại vú: so sánh độ an toàn, mức độ hài lòng và kết quả thẩm mỹ https://news.medxy.ai/ja/67740-2/Medxy AIja2026-08-26T14:29:00-07:00心筋梗塞生存者における様々な食事パターンへの遵守と死亡率との関連 https://news.medxy.ai/vi/social-factors-health-elderly/Medxy AIvi2026-08-26T14:18:00-07:00Kết nối các yếu tố xã hội quyết định sức khỏe với suy yếu đa chiều ở người cao tuổi: Phân tích lớp tiềm ẩn và mạng lưới theo từng lĩnh vực https://news.medxy.ai/ja/elderly-frailty-social-factors/Medxy AIja2026-08-26T14:15:00-07:00高齢者フレイルと社会的決定要因をつなぐ視点：領域別潜在クラス分析とネットワーク解析 https://news.medxy.ai/zh/child-leukemia-risks/Medxy AIzh2026-08-26T14:13:00-07:00年幼急性淋巴细胞白血病患儿接受全身照射：长期风险究竟如何？ https://news.medxy.ai/vi/long-term-risks-radiotherapy/Medxy AIvi2026-08-26T14:13:00-07:00Đánh giá nguy cơ dài hạn của xạ trị toàn thân ở trẻ nhỏ mắc bệnh bạch cầu lymphoblastic cấp https://news.medxy.ai/ja/airway-management-communication/Medxy AIja2026-08-26T14:09:00-07:00共有気道管理のコミュニケーションをつなぐ：多施設麻酔科医調査から見えた課題と示唆 https://news.medxy.ai/technology-guided-diet-counseling-training-enhances-resident-physicians-shared-decision-making-skills-in-primary-care/Medxy AIen2026-08-26T13:40:00-07:00Technology-Guided Diet Counseling Training Enhances Resident Physicians’ Shared Decision-Making Skills in Primary Care https://news.medxy.ai/zh/immune-mediated-disease-micron21/Medxy AIzh2026-08-26T11:56:00-07:00免疫介导性疾病与中心性浆液性脉络膜视网膜病变：MICRoN 报告21的临床启示 https://news.medxy.ai/zh/eczema-treatment-comparison/Medxy AIzh2026-08-26T07:19:00-07:00线上与线下特应性皮炎管理疗效相当：大型随机试验带来的启示 https://news.medxy.ai/plasma-pomc-as-a-predictive-biomarker-for-silent-corticotroph-adenomas-in-non-functioning-pituitary-tumors/Medxy AIen2026-08-26T07:06:00-07:00Plasma POMC as a Predictive Biomarker for Silent Corticotroph Adenomas in Non-Functioning Pituitary Tumors https://news.medxy.ai/tp53-mutated-clonal-hematopoiesis-drives-pro-inflammatory-phenotype-and-predicts-poor-outcomes-after-car-t-cell-therapy/Medxy AIen2026-08-26T06:58:00-07:00TP53-Mutated Clonal Hematopoiesis Drives Pro-Inflammatory Phenotype and Predicts Poor Outcomes After CAR T-Cell Therapy https://news.medxy.ai/integrated-40-gene-expression-profile-enhances-prognostic-precision-and-guides-adjuvant-radiation-in-high-risk-cutaneous-squamous-cell-carcinoma/Medxy AIen2026-08-26T06:57:00-07:00Integrated 40-Gene Expression Profile Enhances Prognostic Precision and Guides Adjuvant Radiation in High-Risk Cutaneous Squamous Cell Carcinoma https://news.medxy.ai/ja/67923-2/Medxy AIja2026-08-26T06:46:00-07:00局所投与ロシグリタゾン：続発性リンパ浮腫に対する新規抗線維化療法の可能性 https://news.medxy.ai/ja/mission-va-study/Medxy AIja2026-08-26T06:43:00-07:00MISSION法はVAの専門診療紹介と待機時間をどう変えたか：全国コホート研究 https://news.medxy.ai/long-term-efficacy-and-visual-field-outcomes-of-selective-laser-trabeculoplasty-in-glaucoma-management/Medxy AIen2026-08-26T06:30:00-07:00Long-Term Efficacy and Visual Field Outcomes of Selective Laser Trabeculoplasty in Glaucoma Management https://news.medxy.ai/ja/icu-frailty-elderly/Medxy AIja2026-08-26T06:28:00-07:00敗血症性ショック後の高齢者にみられるICU後フレイル：主要予測因子と臨床的意義 https://news.medxy.ai/post-icu-frailty-in-older-adults-following-septic-shock-key-predictors-and-clinical-implications/Medxy AIen2026-08-26T06:28:00-07:00Post-ICU Frailty in Older Adults Following Septic Shock: Key Predictors and Clinical Implications https://news.medxy.ai/ja/67827-2/Medxy AIja2026-08-26T06:23:00-07:00遺伝性運動失調症における非遺伝的因子の解明：SCA6およびSCA27Bコホートからの知見 https://news.medxy.ai/ja/diabetes-drug-comparison/Medxy AIja2026-08-26T06:20:00-07:00中国人2型糖尿病患者におけるbofanglutideとsemaglutideの有効性・安全性比較：第2b相試験からの示唆 https://news.medxy.ai/robotic-living-donor-hepatectomy-one-year-prospective-insights-into-donor-quality-of-life-and-psychosocial-outcomes/Medxy AIen2026-08-26T06:03:00-07:00Robotic Living Donor Hepatectomy: One-Year Prospective Insights into Donor Quality of Life and Psychosocial Outcomes https://news.medxy.ai/immune-mediated-disorders-and-central-serous-chorioretinopathy-clinical-insights-from-the-micron-report-21/Medxy AIen2026-08-26T05:55:00-07:00Immune-Mediated Disorders and Central Serous Chorioretinopathy: Clinical Insights from the MICRoN Report 21 https://news.medxy.ai/reversing-epigenetic-aging-in-psoriasis-the-impact-of-tildrakizumab-over-52-weeks/Medxy AIen2026-08-26T05:39:00-07:00Reversing Epigenetic Aging in Psoriasis: The Impact of Tildrakizumab over 52 Weeks https://news.medxy.ai/janus-kinase-inhibitors-transforming-treatment-paradigms-in-lymphomas-and-immune-mediated-complications/Medxy AIen2026-08-26T05:32:00-07:00Janus Kinase Inhibitors: Transforming Treatment Paradigms in Lymphomas and Immune-Mediated Complications https://news.medxy.ai/unveiling-metabolic-signatures-glucose-and-methionine-pet-imaging-in-disorders-of-consciousness-post-brain-injury/Medxy AIen2026-08-26T05:24:00-07:00Unveiling Metabolic Signatures: Glucose and Methionine PET Imaging in Disorders of Consciousness Post-Brain Injury https://news.medxy.ai/bridging-the-communication-gap-in-shared-airway-management-insights-from-a-multicenter-survey-of-anesthesiologists/Medxy AIen2026-08-26T05:09:00-07:00Bridging the Communication Gap in Shared Airway Management: Insights from a Multicenter Survey of Anesthesiologists https://news.medxy.ai/teprotumumab-versus-intravenous-glucocorticoids-in-thyroid-eye-disease-insights-from-a-japanese-mri-study/Medxy AIen2026-08-26T05:07:00-07:00Teprotumumab Versus Intravenous Glucocorticoids in Thyroid Eye Disease: Insights from a Japanese MRI Study https://news.medxy.ai/zh/40-gene-expression/Medxy AIzh2026-08-26T04:58:00-07:00整合型40基因表达谱提升高危皮肤鳞状细胞癌预后评估，并有助于指导辅助放疗 https://news.medxy.ai/vi/immune-mediated-retinal-disease/Medxy AIvi2026-08-26T04:55:00-07:00Bệnh qua trung gian miễn dịch và bệnh lý hắc mạc và võng mạc trung tâm thanh dịch: Những ghi nhận lâm sàng từ báo cáo MICRoN 21 https://news.medxy.ai/alixorexton-a-novel-oral-orexin-2-receptor-agonist-shows-promising-safety-and-efficacy-in-narcolepsy-type-1-insights-from-the-vibrance-1-phase-2-trial/Medxy AIen2026-08-26T04:51:00-07:00Alixorexton, a Novel Oral Orexin 2 Receptor Agonist, Shows Promising Safety and Efficacy in Narcolepsy Type 1: Insights from the Vibrance-1 Phase 2 Trial https://news.medxy.ai/oncoplastic-reconstruction-versus-reduction-mammoplasty-in-macromastia-safety-satisfaction-and-aesthetic-outcomes-compared/Medxy AIen2026-08-26T04:47:00-07:00Oncoplastic Reconstruction Versus Reduction Mammoplasty in Macromastia: Safety, Satisfaction, and Aesthetic Outcomes Compared https://news.medxy.ai/zh/pioglitazone-anti-fibrosis/Medxy AIzh2026-08-26T04:46:00-07:00局部罗格列酮：继发性淋巴水肿的潜在抗纤维化新疗法 https://news.medxy.ai/vi/immune-aging-car-t-cell/Medxy AIvi2026-08-26T04:44:00-07:00Lão hóa miễn dịch: Rào cản then chốt đối với liệu pháp CAR T-cell CD19 trong bệnh bạch cầu lympho mạn tính https://news.medxy.ai/zh/mission-va-referral-waittime/Medxy AIzh2026-08-26T04:43:00-07:00《MISSION法案》对VA专科转诊与等待时间的影响：一项全国队列研究 https://news.medxy.ai/vi/mission-act-impact/Medxy AIvi2026-08-26T04:42:00-07:00Đánh giá tác động của Đạo luật MISSION đối với chuyển tuyến chuyên khoa và thời gian chờ tại VA: Nghiên cứu đoàn hệ quốc gia https://news.medxy.ai/zh/tech-guided-diet-training/Medxy AIzh2026-08-26T04:41:00-07:00技术引导饮食咨询培训可提升住院医师在基层医疗中的共同决策能力 https://news.medxy.ai/zh/67889-2/Medxy AIzh2026-08-26T04:40:00-07:00逆转银屑病患者的表观遗传衰老：Tildrakizumab 治疗 52 周的影响 https://news.medxy.ai/zh/ai-oct-basal-cell-carcinoma/Medxy AIzh2026-08-26T04:38:00-07:00AI辅助线场共聚焦光学相干断层成像：亚临床基底细胞癌早期检出的最新证据与临床前景 https://news.medxy.ai/vi/lc-oct-ai-cancer/Medxy AIvi2026-08-26T04:37:00-07:00LC-OCT hỗ trợ AI trong phát hiện sớm ung thư biểu mô tế bào đáy dưới lâm sàng: Bằng chứng hiện nay và triển vọng lâm sàng https://news.medxy.ai/ai-assisted-line-field-confocal-optical-coherence-tomography-for-early-detection-of-subclinical-basal-cell-carcinoma-current-evidence-and-clinical-prospects/Medxy AIen2026-08-26T04:37:00-07:00AI-Assisted Line-Field Confocal Optical Coherence Tomography for Early Detection of Subclinical Basal Cell Carcinoma: Current Evidence and Clinical Prospects https://news.medxy.ai/vi/microbiota-transplant-treatment/Medxy AIvi2026-08-26T04:34:00-07:00Cấy ghép hệ vi sinh vật phân: Hướng điều trị đầy hứa hẹn cho bệnh ghép chống chủ cấp kháng steroid https://news.medxy.ai/zh/jak-inhibitors-lymphoma-treatment/Medxy AIzh2026-08-26T04:33:00-07:00JAK抑制剂：重塑淋巴瘤与免疫并发症治疗格局 https://news.medxy.ai/vi/janus-kinase-inhibitors/Medxy AIvi2026-08-26T04:32:00-07:00Thuốc ức chế Janus kinase: Thay đổi chiến lược điều trị lymphoma và các biến chứng qua trung gian miễn dịch https://news.medxy.ai/ja/attrv-early-diagnosis/Medxy AIja2026-08-26T04:32:00-07:00家族内遺伝学的スクリーニングが切り開くATTRv早期診断と予後改善 https://news.medxy.ai/vi/glaucoma-treatment-quang-dong/Medxy AIvi2026-08-26T04:31:00-07:00Quang đông bè chọn lọc trong điều trị glaucoma: Hiệu quả dài hạn và ảnh hưởng lên thị trường https://news.medxy.ai/vi/microvascular-leakage-indices/Medxy AIvi2026-08-26T04:29:00-07:00Đánh giá tính đặc hiệu của các chỉ số thoát dịch mao mạch trong suy tim: Hàm ý đối với thực hành lâm sàng https://news.medxy.ai/zh/elderly-sepsis-survivors/Medxy AIzh2026-08-26T04:28:00-07:00老年脓毒性休克幸存者的ICU后衰弱：关键预测因素及临床启示 https://news.medxy.ai/zh/67838-2/Medxy AIzh2026-08-26T04:27:00-07:00GLP1R R131Q 变异：维持 2 型糖尿病患者 β 细胞功能及增强 GLP-1RA 疗效的遗传关键 https://news.medxy.ai/vi/67836-2/Medxy AIvi2026-08-26T04:26:00-07:00Biến thể GLP1R R131Q: Chìa khóa di truyền giúp bảo tồn chức năng tế bào beta và tăng cường hiệu quả của GLP-1RA trong bệnh đái tháo đường tuýp 2. https://news.medxy.ai/glp1r-r131q-variant/Medxy AIen2026-08-26T04:26:00-07:00GLP1R R131Q Variant: A Genetic Key to Preserving β-Cell Function and Enhancing GLP-1RA Efficacy in Type 2 Diabetes https://news.medxy.ai/vi/pet-glucose-methionine/Medxy AIvi2026-08-26T04:24:00-07:00Giải mã dấu ấn chuyển hóa: Hình ảnh PET glucose và methionine trong rối loạn ý thức sau tổn thương não https://news.medxy.ai/vi/67825-2/Medxy AIvi2026-08-26T04:23:00-07:00Khám phá các yếu tố phi di truyền ảnh hưởng đến chứng thất điều di truyền: Những hiểu biết từ các nhóm bệnh nhân SCA6 và SCA27B https://news.medxy.ai/zh/sentinel-lymph-node-biopsy-3/Medxy AIzh2026-08-26T04:22:00-07:00前哨淋巴结活检在非典型子宫内膜增生中的临床价值：来自多中心队列研究的启示 https://news.medxy.ai/vi/guard-node-biopsy-endometrial-hyperplasia/Medxy AIvi2026-08-26T04:21:00-07:00Sinh thiết hạch lính gác trong tăng sản nội mạc tử cung không điển hình: Góc nhìn từ nghiên cứu đoàn hệ đa trung tâm https://news.medxy.ai/zh/bofanglutide-vs-semaglutide/Medxy AIzh2026-08-26T04:20:00-07:00Bofanglutide 与 semaglutide 在中国 2 型糖尿病患者中的疗效与安全性比较：来自 2b 期试验的见解 https://news.medxy.ai/vi/bofanglutide-semaglutide-comparison/Medxy AIvi2026-08-26T04:20:00-07:00Bofanglutide và Semaglutide trong đái tháo đường type 2 ở người Trung Quốc: So sánh hiệu quả và độ an toàn từ thử nghiệm pha 2b https://news.medxy.ai/vi/eczema-treatment-comparison-2/Medxy AIvi2026-08-26T04:19:00-07:00Chăm sóc trực tuyến và khám trực tiếp trong điều trị viêm da cơ địa: Bằng chứng từ một thử nghiệm ngẫu nhiên quy mô lớn https://news.medxy.ai/zh/breast-reconstruction-perfusion/Medxy AIzh2026-08-26T04:17:00-07:00用 SPY-PHI QP 确定预测乳房重建中乳房切除术后皮肤坏死的定量灌注阈值：研究发现与临床启示 https://news.medxy.ai/vi/blood-perfusion-threshold/Medxy AIvi2026-08-26T04:17:00-07:00Xác định ngưỡng tưới máu định lượng bằng SPY-PHI QP để dự đoán hoại tử da sau cắt tuyến vú trong tái tạo vú: phát hiện và ý nghĩa lâm sàng https://news.medxy.ai/zh/eyelid-closure-methods/Medxy AIzh2026-08-26T04:16:00-07:00上睑成形术切口闭合：皮内缝合与连续缝合哪种更优？ https://news.medxy.ai/vi/eyelid-reconstruction-comparison/Medxy AIvi2026-08-26T04:15:00-07:00Đóng da trong tạo hình mi trên: So sánh khâu trong bì và khâu liên tục để tối ưu kết quả https://news.medxy.ai/zh/hfre-treatment-advances/Medxy AIzh2026-08-26T04:14:00-07:00瑞典登记研究揭示HFrEF四联治疗优化新进展：依从性、持续用药与结局 https://news.medxy.ai/vi/67775-2/Medxy AIvi2026-08-26T04:14:00-07:00Tối ưu hóa việc quản lý suy tim phân suất tống máu giảm: Những hiểu biết từ cơ sở dữ liệu Thụy Điển về mức độ tuân thủ và duy trì liệu pháp phối hợp bốn thuốc https://news.medxy.ai/zh/fendrr-kras-ball-subtype/Medxy AIzh2026-08-26T04:13:00-07:00IGH::FENDRR重排与KRAS突变揭示一种全新B-ALL亚型：化疗反应差 https://news.medxy.ai/ja/long-term-risk-whole-body-irradiation/Medxy AIja2026-08-26T04:13:00-07:00小児急性リンパ性白血病に対する全身照射の長期リスクを検証する https://news.medxy.ai/vi/67768-2/Medxy AIvi2026-08-26T04:12:00-07:00Sự tái tổ hợp IGH::FENDRR và đột biến KRAS hé lộ một phân nhóm B-ALL mới có đáp ứng kém với hóa trị https://news.medxy.ai/evaluating-the-specificity-of-capillary-leak-indices-in-heart-failure-implications-for-clinical-practice/Medxy AIen2026-08-26T03:29:00-07:00Evaluating the Specificity of Capillary Leak Indices in Heart Failure: Implications for Clinical Practice https://news.medxy.ai/unveiling-non-genetic-influences-on-hereditary-ataxia-insights-from-sca6-and-sca27b-cohorts/Medxy AIen2026-08-26T03:23:00-07:00Unveiling Non-Genetic Influences on Hereditary Ataxia: Insights from SCA6 and SCA27B Cohorts https://news.medxy.ai/vi/68063-2/Medxy AIvi2026-08-26T03:09:00-07:00Phá vỡ rào cản giao tiếp trong quản lý đường thở dùng chung: Những hiểu biết từ khảo sát đa trung tâm trên các bác sĩ gây mê https://news.medxy.ai/enhancing-parathyroid-gland-preservation-in-total-thyroidectomy-efficacy-of-near-infrared-autofluorescence-probe-pteye-versus-visual-identification/Medxy AIen2026-08-26T03:01:00-07:00Enhancing Parathyroid Gland Preservation in Total Thyroidectomy: Efficacy of Near-Infrared Autofluorescence Probe (PTeye) Versus Visual Identification https://news.medxy.ai/long-term-survival-benefit-of-daratumumab-with-lenalidomide-and-dexamethasone-in-transplant-ineligible-newly-diagnosed-multiple-myeloma-insights-from-the-maia-final-analysis/Medxy AIen2026-08-26T03:00:00-07:00Long-Term Survival Benefit of Daratumumab with Lenalidomide and Dexamethasone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Insights from the MAIA Final Analysis https://news.medxy.ai/zh/thyroid-protein-amyloidosis/Medxy AIzh2026-08-26T02:33:00-07:00遗传性转甲状腺素蛋白淀粉样变性中的级联基因筛查：促进更早诊断与改善预后 https://news.medxy.ai/vi/genetic-screening-amyloidosis/Medxy AIvi2026-08-26T02:32:00-07:00Sàng lọc di truyền theo chuỗi trong thoái hóa amyloidosis transthyretin di truyền: mở ra chẩn đoán sớm và cải thiện kết cục https://news.medxy.ai/cascade-genetic-screening-in-hereditary-transthyretin-amyloidosis-unlocking-earlier-diagnosis-and-improved-outcomes/Medxy AIen2026-08-25T21:32:09-07:00Cascade Genetic Screening in Hereditary Transthyretin Amyloidosis: Unlocking Earlier Diagnosis and Improved Outcomes https://news.medxy.ai/site-specific-apo-ai-glycation-impairs-hdl-function-and-promotes-atherosclerosis-in-diabetes/Medxy AIen2026-08-25T21:30:36-07:00Site-Specific Apo AI Glycation Impairs HDL Function and Promotes Atherosclerosis in Diabetes https://news.medxy.ai/association-of-adherence-to-various-dietary-patterns-with-mortality-among-survivors-of-myocardial-infarction-an-evidence-based-review/Medxy AIen2026-08-25T21:28:52-07:00Association of Adherence to Various Dietary Patterns With Mortality Among Survivors of Myocardial Infarction: An Evidence-Based Review https://news.medxy.ai/bridging-social-determinants-of-health-and-multidimensional-frailty-among-older-adults-a-domain-specific-latent-class-and-network-analysis/Medxy AIen2026-08-25T21:17:54-07:00Bridging Social Determinants of Health and Multidimensional Frailty Among Older Adults: A Domain-Specific Latent Class and Network Analysis https://news.medxy.ai/ja/alpha-gal-syndrome-transfusion/Medxy AIja2026-08-25T20:48:00-07:00輸血関連alpha-gal症候群の疫学的知見：リスク層別化と臨床的意義 https://news.medxy.ai/ja/3d-face-analysis/Medxy AIja2026-08-25T20:29:00-07:00スマートフォンで実現する3D顔面形状解析：顔面神経麻痺を客観的に評価・追跡する新手法 https://news.medxy.ai/vi/67244-2/Medxy AIvi2026-08-25T20:08:00-07:00Đẩy nhanh tiến độ điều trị bằng i-ốt phóng xạ cho ung thư tuyến giáp thể biệt hóa: Quy trình mới cho kỹ thuật chẩn đoán hình ảnh ¹³¹I thực hiện 24 giờ sau khi dùng rhTSH https://news.medxy.ai/ja/rare-genetic-obesity-care/Medxy AIja2026-08-25T20:07:00-07:00希少遺伝性肥満に対する協調的かつ精密な診療：専門施設と構造化モニタリングに関する欧州専門家コンセンサス https://news.medxy.ai/vi/rare-genetic-obesity-care-2/Medxy AIvi2026-08-25T20:06:00-07:00Chăm sóc chính xác, phối hợp cho béo phì di truyền hiếm gặp: Đồng thuận chuyên gia châu Âu về trung tâm chuyên môn và theo dõi có cấu trúc https://news.medxy.ai/zh/rare-genetic-obesity/Medxy AIzh2026-08-25T20:06:00-07:00罕见遗传性肥胖的协同精准诊疗：欧洲专家关于专家中心与结构化监测的共识 https://news.medxy.ai/ja/h-pylori-insulin-resistance-2/Medxy AIja2026-08-25T20:04:00-07:00Helicobacter pylori感染とインスリン抵抗性の関連を再検証：欧州コホートにおける頻度主義的解析とBayesian解析からの知見 https://news.medxy.ai/zh/infant-stool-short-chain-fatty-acids/Medxy AIzh2026-08-25T20:03:00-07:00母婴粪便短链脂肪酸与胰岛自身免疫：未见直接关联 https://news.medxy.ai/ja/short-chain-fatty-acids/Medxy AIja2026-08-25T20:02:00-07:00母子の糞便中短鎖脂肪酸：膵島自己免疫の進行とは直結しない https://news.medxy.ai/vi/short-chain-fatty-acids-2/Medxy AIvi2026-08-25T20:02:00-07:00Axit béo chuỗi ngắn trong phân ở cặp mẹ–con: Không có liên hệ trực tiếp với sự phát triển tự miễn đảo tụy https://news.medxy.ai/ja/htd1801-diabetes-trial/Medxy AIja2026-08-25T20:01:00-07:00HTD1801単剤療法が2型糖尿病の血糖管理と心代謝健康を大幅に改善：56週間第3相試験の結果